PSMA7 and cancer: Although PSMA7-resistant compounds accounted for the majority, we found six compounds with negative R-values and FDR ≤ 0.05 in GDSC that might be sensitive to cancers with elevated PSMA7 expression (Fig. 6A, Table 2).